Latest Posts

All Posts

An Interview with Connie Cepko - Gene Therapy, Plasmid Tools and Insights to Success

Posted by Tyler Ford on Dec 8, 2015 10:30:00 AM

We recently sat down with Addgene Board Member, depositor, and Harvard Medical School researcher Connie Cepko. Listen to the podcast below to hear all about the research being conducted in Professor Cepko's lab and to get some insight into her management and mentoring styles. If you'd like to learn more about Professor Cepko's recent work on developing GFP-activated proteins, read our recent blog post.

Read More >

Topics: Interview, Viral Vectors, Podcast

New Tool for Lineage Tracing: The ClonTracer Library

Posted by Tyler Ford on Sep 22, 2015 10:30:00 AM

This article is based on an interview with Novartis researcher, Carrie Bhang.

The ClonTracer Library, deposited by Carrie Bhang, a research investigator in the In Vivo Pharmacology group at Novartis Oncology, is an exciting new tool that allows researchers to individually label millions of mammalian cells through lentiviral infection and to monitor their abundance and clonal dynamics over time using next generation sequencing (NGS). The library was developed when Carrie was a post-doc in Frank Stegmeier’s lab in Novartis Oncology. 

Read More >

Topics: Interview, Viral Vectors, pooled libraries, Cancer

Donations from Addgene to Yield Answers for Rare Disease Researchers

Posted by Kendall Morgan on Sep 15, 2015 10:30:00 AM

Every year, the Rare Genomics Institute sponsors a global competition for researchers working on rare diseases, offering them the chance to win some of the latest tools and technologies in life sciences research. The rare disease research community has certainly noticed: This year, the BeHEARD (Helping Empower and Accelerate Research Discoveries) Award attracted submissions from 99 universities and foundations in 21 countries.

“Over $600,000 worth of cutting-edge technologies were awarded to study 31 rare diseases,” said Claudia OuYang, BeHEARD Co-Director in a release. The research teams studying four of those rare diseases will receive plasmids from Addgene worth a total of $5000.

Read More >

Topics: Scientific Sharing, Interview

Addgene Welcomes John Doench to the Advisory Board

Posted by Tyler Ford on Aug 13, 2015 10:30:00 AM

The Addgene Advisory Board consists of prominent members of the bioscience and tech transfer communities who help guide and promote Addgene in its mission to make research easier. Addgene is excited to announce that we’ve added John G. Doench, PhD to the Advisory Board. John Doench is Associate Director of the Genetic Perturbation Platform at the Broad Institute and has worked with many Addgenies to help improve the understanding, curation, and explanation of our CRISPR resources. We recently sat down with Dr. Doench for an interview to help further introduce him to the Addgene community.

Read More >

Topics: Interview, Inside Addgene, CRISPR, Podcast

Protein Tagging with CRISPR/Cas9: A Conversation with Mendenhall and Myers

Posted by Kendall Morgan on Jul 28, 2015 10:30:00 AM

As Eric Mendenhall of the University of Alabama in Huntsville explains it, a major goal in his laboratory is to understand the function of the non-coding portion of the genome. Mendenhall and Richard Myers of HudsonAlpha (where Mendenhall is also an adjunct faculty member) have together been working toward this goal for years as members of the ENCyclopedia of DNA Elements Project (ENCODE), an NIH-funded effort to define all of the functional elements in the human genome.

Read More >

Topics: Interview, CRISPR

Click here to subscribe to the Addgene Blog
 
Subscribe

 

Recent Posts